February 1, 2023
Clearmind Medicine (CMND) Reports Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Clearmind Medicine Inc. (NASDAQ: CMND) today announced that as part of its ongoing collaboration with the Bar-Ilan University, Israel and Professor Gal Yadid, from the Gonda Multidisciplinary Brain Research Center, a new pre-clinical trial (the “trial” ) resulted in …